Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells
Background: Drug combination therapy to treat cancer is a strategic approach to increase successful treatment rate. Optimizing combination regimens is vital to increase therapeutic efficacy with minimal side effects. Materials and methods: In the present study, we evaluated the in vitro cytotoxicity...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Dove Medical Press
2018
|
| Subjects: |